Clinical Trial

9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease

Recruiting
View on ClinicalTrials.gov →
Summary
It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-08-27; most recent amendment 2024-01-02.
Status change: Not Yet Recruiting → Recruiting 2023-01-02
Trial Details
NCT Number NCT04071925
Lead Sponsor University Hospital, Ghent
Conditions Urethral Stricture
Enrollment 1,000 participants
Start Date 2019-09-01
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-03